{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:21:26Z","timestamp":1788258086794,"version":"build-2803163510"},"reference-count":146,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.disamonth.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T16:07:44Z","timestamp":1546099664000},"page":"119-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["The value of harm reduction for injection drug use: A clinical and public health ethics analysis"],"prefix":"10.1016","volume":"65","author":[{"given":"Laura","family":"Vearrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2018.12.002_bib0001","article-title":"Harm reduction: an approach to reducing risky health behaviours in adolescents","author":"Leslie","year":"2008","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10826080701690680","article-title":"The ethics of harm reduction","volume":"43","author":"Kleinig","year":"2008","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0003","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","article-title":"Harm reduction: come as you are","volume":"21","author":"Marlatt","year":"1996","journal-title":"Addict Behav"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2007.11.020","article-title":"Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate","volume":"19","author":"Christie","year":"2008","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09595239800187011","article-title":"The definition of harm reduction","volume":"17","author":"Lenton","year":"1998","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0006","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/wmh3.123","article-title":"Tough on drugs: law and order dominance and the neglect of public health in US drug policy","volume":"6","author":"Neill","year":"2014","journal-title":"World Med Health Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0008","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1037\/0003-066X.53.11.1199","article-title":"Toward a psychology of harm reduction","volume":"53","author":"MacCoun","year":"1998","journal-title":"Am Psychol"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0009","first-page":"1378","article-title":"Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0010","article-title":"The societal cost of heroin use disorder in the United States","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0011","first-page":"1027","article-title":"Collateral damage: no re-entry for drug offenders","volume":"47","author":"Demleitner","year":"2002","journal-title":"Vill L Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0012","first-page":"839","article-title":"Collateral damage in the war on drugs","volume":"47","author":"Boyd","year":"2002","journal-title":"Vill L Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0013","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/09595230500404145","article-title":"Ushering in another harm reduction era? Discursive authenticity, drug policy and research","volume":"24","author":"Hathaway","year":"2005","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugpo.2006.12.002","article-title":"Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction","volume":"18","author":"Irwin","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/09595230500263905","article-title":"Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics","volume":"24","author":"Fry","year":"2005","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/medethics-2014-102282","article-title":"Defending the four principles approach as a good basis for good medical practice and therefore for good medical ethics","volume":"41","author":"Gillon","year":"2015","journal-title":"J Med Ethics"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0018","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.PHH.0000324563.87780.67","article-title":"Preparedness: medical ethics versus public health ethics","volume":"14","author":"Swain","year":"2008","journal-title":"J Pub Health Manag Pract"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0019","series-title":"Principles of Biomedical Ethics","author":"Childress","year":"2001"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006732.pub2","article-title":"Interventions for improving the adoption of shared decision making by healthcare professionals","volume":"5","author":"L\u00e9gar\u00e9","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0021","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0022","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13181-012-0269-4","article-title":"Dependence and addiction during chronic opioid therapy","volume":"8","author":"Juurlink","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0023","series-title":"Definitions Related to the Use of Opioids for the Treatment of Pain. Consensus Document From the American Academy of Pain Medicine","author":"Savage","year":"2001"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.2006.163.5.764","article-title":"What's in a word? Addiction versus dependence in DSM-V","author":"O'Brien","year":"2006","journal-title":"Am Psychiatric Assoc"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0025","series-title":"Physical Dependence and Addiction: An Important Distinction","author":"The National Alliance of Advocates for Buprenorphine Treatment","year":"2016"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0026","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","article-title":"Opioid pseudoaddiction\u2014an iatrogenic syndrome","volume":"36","author":"Weissman","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0027","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugpo.2011.02.003","article-title":"Drug policy, harm and human rights: a rationalist approach","volume":"22","author":"Stevens","year":"2011","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1037\/teo0000056","article-title":"Fostering client autonomy in addiction rehabilitative practice: the role of therapeutic \u201cpresence\u201d","volume":"37","author":"Kinsella","year":"2017","journal-title":"J Theor Philos Psychol"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0029","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.annemergmed.2014.11.015","article-title":"Association of emergency department opioid initiation with recurrent opioid use","volume":"65","author":"Hoppe","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.annemergmed.2015.11.033","article-title":"Emergency department prescription opioids as an initial exposure preceding addiction","volume":"68","author":"Butler","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0031","first-page":"1","article-title":"Is addiction a brain disease?","author":"Berridge","year":"2017","journal-title":"Neuroethics"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0032","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-1-4020-8509-3_26","article-title":"Reconceptualizing sociogeographic context for the study of drug use, abuse, and addiction","author":"Kwan","year":"2008","journal-title":"Geogr Drug Addict"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0033","article-title":"The likely cause of addiction has been discovered, and it is not what you think","author":"Hari","year":"2015","journal-title":"Huffpost"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0034","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1360-0443.2008.02336.x","article-title":"Dilemmas in harm minimization","volume":"104","author":"Weatherburn","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0035","series-title":"Harm Reduction: Helping or Hurting Addicts? \u2013 Part Two","author":"Stockard","year":"2014"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0036","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2105\/AJPH.2006.086256","article-title":"Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility","volume":"97","author":"Kerr","year":"2007","journal-title":"Am J Public Health"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0037","series-title":"European Report On Drug Consumption Rooms","author":"Hedrich","year":"2004"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0038","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199904160-00002","article-title":"Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak","volume":"13","author":"Schechter","year":"1999","journal-title":"Aids"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1378\/chest.132.4_MeetingAbstracts.692","article-title":"Naloxone-induced pulmonary edema","volume":"132","author":"Bansal","year":"2007","journal-title":"CHEST J"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740338.6.2.125","article-title":"Naloxone treatment in opioid addiction: the risks and benefits","volume":"6","author":"van Dorp","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/SIH.0000000000000182","article-title":"Patient simulation for assessment of layperson management of opioid overdose with intranasal naloxone in a recently released prisoner cohort","volume":"12","author":"Kobayashi","year":"2017","journal-title":"Simul Healthc"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0042","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0043","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6612a2","article-title":"Methadone prescribing and overdose and the association with medicaid preferred drug list policies\u2014United States, 2007\u20132014","volume":"66","author":"Faul","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0044","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132015","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0045","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0046","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/ewjm.172.1.11","article-title":"Toxicology and pathology of deaths related to methadone: retrospective review","volume":"172","author":"Karch","year":"2000","journal-title":"West J Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0047","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jflm.2017.05.010","article-title":"A possible biomarker for methadone related deaths","volume":"49","author":"Argo","year":"2017","journal-title":"J Forensic Legal Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0048","first-page":"353","article-title":"Medical error-the third leading cause of death in the US","author":"Makary","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0049","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.13776","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"16","author":"Rudd","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1037\/h0088437","article-title":"Transtheoretical therapy: toward a more integrative model of change","volume":"19","author":"Prochaska","year":"1982","journal-title":"Psychotherapy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0051","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"J Substance Abuse Treat"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0052","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.psychres.2014.11.023","article-title":"The reductions in monetary cost and gains in productivity with methadone maintenance treatment: one year follow-up","volume":"225","author":"Hsiao","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0053","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0054","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s10461-013-0584-z","article-title":"Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users","volume":"18","author":"Reddon","year":"2014","journal-title":"AIDS Behav"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00002018-200022030-00002","article-title":"A risk-benefit analysis of methadone maintenance treatment","volume":"22","author":"Bell","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0056","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0057","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.2015.6303","article-title":"Ideological anachronism involving needle and syringe exchange programs: Lessons from the indiana hiv outbreak","volume":"314","author":"Rich","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0058","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMp1507252","article-title":"Threading the Needle \u2014 How to Stop the HIV Outbreak in Rural Indiana","volume":"373","author":"Strathdee","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0059","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0060","series-title":"The Oxford Handbook of Substance Use and Substance Use Disorders","article-title":"Serious mental illness","author":"Mueser","year":"2016"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0061","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0062","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02287327","article-title":"Retention in publicly funded methadone maintenance treatment in two western states","volume":"32","author":"Deck","year":"2005","journal-title":"J Behav Health Serv Res"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0063","doi-asserted-by":"crossref","first-page":"22902","DOI":"10.3402\/jchimp.v4.22902","article-title":"Buprenorphine Outpatient Outcomes Project: can Suboxone be a viable outpatient option for heroin addiction?","volume":"4","author":"Sittambalam","year":"2014","journal-title":"J Commun Hosp Intern Med Persp"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0064","series-title":"The Future of Public Health","author":"Institute of Medicine","year":"1988"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0065","series-title":"Public Health Ethics: Cases Spanning the Globe","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-23847-0","author":"Barrett","year":"2016"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0066","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2307\/3096971","article-title":"Setting the public agenda:\u201cStreet crime\u201d and drug use in American politics","volume":"41","author":"Beckett","year":"1994","journal-title":"Soc Prob"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0067","first-page":"2007","article-title":"Address to the nation on the national drug control strategy","volume":"24","author":"Bush","year":"1989","journal-title":"\u00daltimo Acesso"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0068","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugpo.2006.11.003","article-title":"How the harm reduction movement contrasts itself against punitive prohibition","volume":"18","author":"Tammi","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0069","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10611-009-9202-4","article-title":"Drug markets and the selective use of violence","volume":"52","author":"Friman","year":"2009","journal-title":"Crime Law Soc Change"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/00036849200000036","article-title":"Is property crime caused by drug use or by drug enforcement policy?","volume":"24","author":"Benson","year":"1992","journal-title":"Appl Econ"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0071","first-page":"613","article-title":"Organized crime and prohibition: what difference does legalization make","volume":"15","author":"Demleitner","year":"1994","journal-title":"Whittier L Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0072","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.drugalcdep.2012.02.005","article-title":"Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study","volume":"124","author":"Havnes","year":"2012","journal-title":"Drug Alcohol Depen"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0073","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.2011.03637.x","article-title":"Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study","volume":"107","author":"Bukten","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0074","first-page":"282","article-title":"Needle exchange programs and experience of violence in an inner city neighborhood","volume":"28","author":"Galea","year":"2001","journal-title":"JAIDS"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2105\/AJPH.90.12.1933","article-title":"Trends in crime and the introduction of a needle exchange program","volume":"90","author":"Marx","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0076","series-title":"The Normalisation Thesis\u201320 Years Later","author":"Pennay","year":"2016"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0077","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/003803850203600408","article-title":"The normalization of \u2018sensible'recreational drug use: Further evidence from the North West England longitudinal study","volume":"36","author":"Parker","year":"2002","journal-title":"Sociology"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0078","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/09687637.2015.1118442","article-title":"Normalization and denormalization in different legal contexts: Comparing cannabis and tobacco","volume":"23","author":"Asbridge","year":"2016","journal-title":"Drugs Education, Prevention and Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0079","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1023\/A:1013195108756","article-title":"Impact of needle exchange programs on adolescent perceptions about illicit drug use","volume":"5","author":"Marx","year":"2001","journal-title":"AIDS Behav"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0080","first-page":"S217","article-title":"Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV","volume":"12","author":"Drucker","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0081","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.drugpo.2015.08.013","article-title":"Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005\u20132012","volume":"26","author":"Kim","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0082","series-title":"Syringe Services Programs","author":"U.S. Department of Health and Human Services","year":"2018"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0083","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0749-3797(99)00137-3","article-title":"Occupational needlestick injuries in a metropolitan police force","volume":"18","author":"Lorentz","year":"2000","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0084","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"Bruce","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152804","article-title":"Methadone maintenance treatment promotes referral and uptake of HIV testing and counselling services amongst drug users and their partners","volume":"11","author":"Tran","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0086","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2016.07.006","article-title":"Effectiveness of methadone maintenance therapy and improvement in quality of life following a decade of implementation","volume":"69","author":"Fei","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0087","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0088","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2014.12.009","article-title":"Brief overdose education is sufficient for naloxone distribution to opioid users","volume":"148","author":"Behar","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0089","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08897077.2016.1176978","article-title":"Opioid overdose prevention in a residential care setting: naloxone education and distribution","volume":"38","author":"Pade","year":"2017","journal-title":"Subst Abuse"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2016.05.008","article-title":"Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members","volume":"165","author":"Wagner","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0091","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1377\/hlthaff.25.4.1053","article-title":"What does social justice require for the public's health? Public health ethics and policy imperatives","volume":"25","author":"Gostin","year":"2006","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0092","series-title":"The Six Dimensions of Wellness","author":"Hettler","year":"1976"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0093","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1475-6773.2005.00466.x","article-title":"Benefit\u2013cost in the California treatment outcome project: does substance abuse treatment \u201cpay for itself\u201d","volume":"41","author":"Ettner","year":"2006","journal-title":"Health Serv Res"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0094","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2014.09.007","article-title":"Dynamics in the costs of criminality among opioid dependent individuals","volume":"144","author":"Krebs","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/add.13729","article-title":"The costs of crime during and after publicly funded treatment for opioid use disorders: a population\u2010level study for the state of California","volume":"112","author":"Krebs","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0096","article-title":"Needle exchange programs: an economic evaluation of a local experience","volume":"157","author":"Gold","year":"1997","journal-title":"Can Med Ass J"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0097","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1747-597X-8-25","article-title":"A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada","volume":"8","author":"Jozaghi","year":"2013","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0098","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1747-597X-9-31","article-title":"A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada","volume":"9","author":"Jozaghi","year":"2014","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0099","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF03405487","article-title":"Acceptability of harm reduction interventions: contributions of members of the population to the debate about public health ethics","volume":"100","author":"Dub\u00e9","year":"2009","journal-title":"Can J Pub Health"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13011-015-0022-5","article-title":"Correlates of public support toward federal funding for harm reduction strategies","volume":"10","author":"Kulesza","year":"2015","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0101","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2105\/AJPH.98.Supplement_1.S191","article-title":"Coming home from jail: the social and health consequences of community reentry for women, male adolescents, and their families and communities","volume":"98","author":"Freudenberg","year":"2008","journal-title":"Am J Public Health"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/02791072.2007.10400618","article-title":"Death by drug overdose: impact on families","volume":"39","author":"Da Silva","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0103","series-title":"Public Health Ethics: Cases Spanning the Globe","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-23847-0_1","article-title":"Public health ethics: global cases, practice, and context","author":"Ortmann","year":"2016"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0104","series-title":"Nearly Half of Americans have a Family Member or Close Friend Who's Been Addicted to Drugs","author":"Gramlich","year":"2017"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0105","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0140-6736(16)30308-7","article-title":"Making the case for supervised injection services","volume":"387","author":"Bayoumi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.socscimed.2014.01.051","article-title":"\u2018Safer environment interventions\u2019: a qualitative synthesis of the experiences and perceptions of people who inject drugs","volume":"106","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0107","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1503\/cmaj.130927","article-title":"Supervised injection sites: prejudice should not trump evidence of benefit","volume":"185","author":"Zlotorzynska","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0108","article-title":"Drug consumption rooms: an overview of provision and evidence","year":"2016","journal-title":"Persp Drugs"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0109","article-title":"The Health 202: Supervised injection facilities are illegal in the United States. These cities want to open them anyway","author":"Cunningham","year":"2018","journal-title":"PowerPost"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000110405","article-title":"Typology of injection profiles of clients of a supervised drug consumption facility in Geneva, Switzerland","volume":"14","author":"Dubois-Arber","year":"2008","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0111","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2005.11.011","article-title":"Attendance, drug use patterns, and referrals made from North America's first supervised injection facility","volume":"83","author":"Tyndall","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0112","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/002204260303300306","article-title":"The Sydney Medically Supervised Injecting Centre: Client characteristics and predictors of frequent attendance during the first 12 months of operation","volume":"33","author":"Kimber","year":"2003","journal-title":"J Drug Issues"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0113","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","article-title":"Do supervised injecting facilities attract higher-risk injection drug users","volume":"29","author":"Wood","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/pubmed\/fdl090","article-title":"Changes in injecting practices associated with the use of a medically supervised safer injection facility","volume":"29","author":"Stoltz","year":"2007","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11606-006-0079-y","article-title":"Predictors of hospitalization for injection drug users seeking care for soft tissue infections","volume":"22","author":"Takahashi","year":"2007","journal-title":"J Gen Inter Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/320879","article-title":"Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study","volume":"33","author":"Murphy","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0117","first-page":"595","article-title":"Bacterial infections and skin cleaning prior to injection among intravenous drug users","volume":"107","author":"Vlahov","year":"1992","journal-title":"Pub Health Rep"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0118","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0119","doi-asserted-by":"crossref","first-page":"e3351","DOI":"10.1371\/journal.pone.0003351","article-title":"Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility","volume":"3","author":"Milloy","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0121","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00952990802122457","article-title":"Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility","volume":"34","author":"Milloy","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0122","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.drugpo.2013.11.006","article-title":"Negotiating place and gendered violence in Canada's largest open drug scene","volume":"25","author":"McNeil","year":"2014","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0123","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.socscimed.2008.05.012","article-title":"Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility","volume":"67","author":"Fairbairn","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0124","series-title":"Street Youth in Canada \u2013 Findings From Enhanced Surveillance of Canadian Street Youth, 1999-2003","author":"Public Health Agency of Canada","year":"2006"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0125","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.080808","article-title":"The cost-effectiveness of Vancouver's supervised injection facility","volume":"179","author":"Bayoumi","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1503\/cmaj.081678","article-title":"Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics","volume":"179","author":"Des Jarlais","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0127","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2009.03.004","article-title":"A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility","volume":"21","author":"Andresen","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0128","series-title":"9-1-1 Statistics","author":"National Emergency Number Association","year":"2014"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0129","article-title":"Paramedic: Ambulance delays 'causing harm and deaths'","author":"Cave","year":"2013","journal-title":"BBC News"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","article-title":"The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia","volume":"105","author":"Salmon","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1465-3362.2010.00188.x","article-title":"Needle exchange as a safe haven in an unsafe world","volume":"30","author":"Macneil","year":"2011","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0132","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1465-3362.2009.00025.x","article-title":"Access to health and social services for IDU: the impact of a medically supervised injection facility","volume":"28","author":"Small","year":"2009","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0133","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2006.11.019","article-title":"Public injection settings in Vancouver: physical environment, social context and risk","volume":"18","author":"Small","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0134","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2458-10-327","article-title":"Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study","volume":"10","author":"Lloyd-Smith","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0135","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMc052939","article-title":"Attendance at supervised injecting facilities and use of detoxification services","volume":"354","author":"Wood","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0136","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2850.2011.01810.x","article-title":"Staff concerns in heroin-assisted treatment centres","volume":"19","author":"Demaret","year":"2012","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0137","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0138","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/bjp.bp.114.160986","article-title":"Heroin-assisted treatment: has a controversial treatment come of age?+","volume":"207","author":"Farrell","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13722-017-0104-y","article-title":"Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting","volume":"13","author":"Klimas","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0140","series-title":"Collateral Consequences of Criminal Conviction","author":"Chin","year":"2017"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0141","first-page":"315","article-title":"The war on drugs, the politics of crime, and mass incarceration in the United States","volume":"15","author":"Schoenfeld","year":"2012","journal-title":"J Gend Race Just"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0011128714568427","article-title":"Race differences in drug offending and drug distribution arrests","volume":"63","author":"Mitchell","year":"2017","journal-title":"Crime Delinq"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0143","series-title":"Race, Neighborhood Context, and Drug Enforcement: A Mixed-Method Analysis of Racial Disparities in Drug Arrests","author":"Gaston","year":"2016"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0144","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1360-0443.2010.03049.x","article-title":"Drug policy and the public good: a summary of the book","volume":"105","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0145","doi-asserted-by":"crossref","DOI":"10.1111\/dewb.12003","article-title":"Harm reduction and abortion","volume":"12","author":"Diniz","year":"2012","journal-title":"Dev World Bioeth"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0146","doi-asserted-by":"crossref","unstructured":"Greenwald G. Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. 2009.","DOI":"10.2139\/ssrn.1464837"},{"key":"10.1016\/j.disamonth.2018.12.002_bib0147","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/bjc\/azq038","article-title":"What can we learn from the Portuguese decriminalization of illicit drugs?","volume":"50","author":"Hughes","year":"2010","journal-title":"Br J Criminol"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502918301615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502918301615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T04:30:16Z","timestamp":1662697816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502918301615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":146,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0011502918301615"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2018.12.002","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of harm reduction for injection drug use: A clinical and public health ethics analysis","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}